Another recovery story is Medadvisor (MDR). The stock just doubled, as the company is expected to turn profitable in FY 24.
Quite interesting story : - app connecting pharmacies and patients in Australia, which allows patients to order remotely and also enable patients to get notifications when to take medicine, refill...(free app for patients, while pharmacies pay a monthly subscription), - in the US, again app which connect pharmacies and patients, but monetised differently, mainly via pharma companies which want to communicate about their products by targeting the records of 200 million patients in the US.
My understanding : it is a SAAS model in Australia and more a communication company (depending on pharma marketing budgets) in the US.
New management which seems to do a lot of right things : - in Australia, large cost cutting and price increase to enable the company to turn profitable, - in the US, moving to a digital platform rather than historically sending mails, which has a major impact on profitability.
Not easy to value such a company, but the Australian side of the business looks interesting, as it is sticky and generates a high gross margin.
